Does Dr. HAMEED AHMAD have financial conflicts of interest?

Dr. HAMEED AHMAD (M.D.) has received a total of $388 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $388 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. HAMEED AHMAD?

According to CMS Open Payments data, Dr. HAMEED AHMAD received funding from JANSSEN SCIENTIFIC AFFAIRS ($122), ASTRAZENECA PHARMACEUTICALS ($116), and BAYER HEALTHCARE PHARMACEUTICALS ($53).

Does Dr. HAMEED AHMAD receive research grants or speaking fees?

Dr. HAMEED AHMAD has received $388 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. HAMEED AHMAD

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: KANSAS CITY, MO 64154

NPI Number: 1144437310

LIFETIME INDUSTRY VALUE

$388

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AHMAD is a verified Internal Medicine, Nephrology practitioner based in KANSAS CITY, MO.

Between 2021 and 2024, Dr. AHMAD had an overall industry promotional and research financial footprint of $388 as recorded in the federal CMS Open Payments database.

$388 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AHMAD's primary funding source is JANSSEN SCIENTIFIC AFFAIRS, which accounts for $122 (representing 31.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN SCIENTIFIC AFFAIRS

Rank 1

$122

31.6%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$116

29.9%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 3

$53

13.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.